 |
|
|
|
 |
egories |
 |
 |
New Addition |
 |
|
|
 |
Details: |
 |
|
|
Developing cause-oriented treatment for Parkinson's, Alzheimer's, and Lou Gehrig's diseases based on preventing mitochondrial DNA damage, the earliest recognized event in these neurodegenerative disorders, with proprietary polyamine drug, Tetramine.
|
| URL: |
|
| Title: |
|
| Description: |
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Research and Development - Verne Mendel Medical Corporation. Developing cause-oriented treatment for Parkinson's, Alzheimer's, and Lou Gehrig's diseases based on preventing mitochondrial DNA damage, the earliest recognized event in these neurodegenerative disorders, with proprietary polyamine drug, Tetramine. |
| Specialized in: |
|
|
 |
|
 |
AlteonPharma (Popularity: ): Development of pharmaceutical products for the complications of diabetes and age-related diseases.
Chiroscience (Popularity: ): Chiroscience Group plc is an emerging pharmaceutical company which uses its diverse technology platform to discover and develop novel medicines ...
MDL Information Systems, Inc. (Popularity: ): MDL is a leading provider of integrated logistics and decision support systems that enable a high-throughput environment for research and ...
Key Oncologics (Pty) Ltd, South Africa (Popularity: ): Biopharmaceutical company with a focus on marketing anticancer pharmaceuticals, and conducting oncology clinical trials.
Pharmadigm, Inc. (Popularity: ): Pharmadigm is developing a new class of anti-inflammatory agent useful in the management of acute inflammatory responses associated with burns, ...
Tuberculosis Research Centre (Popularity: ): Established in 1956 under the auspices of the Indian Council of Medical Research, the World Health Organisation and the British ...
SERAF Therapeutics, Inc. (Popularity: ): Early stage pharmaceutical company specializing in targeted delivery of therapeutic componds to specific immune cells as cost-effective therapy for inflammatory ...
Karo Bio AB (Popularity: ): A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.
Mercodia (Popularity: ): Specialising in the research, development, and manufacture of quality in vitro diagnostics products.
Pherin Pharmaceutical (Popularity: ): Pherin Pharmaceuticals is focused on the discovery and development of vomeropherins, a new family of pharmaceutical compounds for the treatment ...
|
 |
Popular Sites |
 |
AlteonPharma (Popularity: ): Development of pharmaceutical products for the complications of diabetes and age-related diseases.
Mercodia (Popularity: ): Specialising in the research, development, and manufacture of quality in vitro diagnostics products.
Chiroscience (Popularity: ): Chiroscience Group plc is an emerging pharmaceutical company which uses its diverse technology platform to discover and develop novel medicines ...
ProCertus BioPharm, Inc. (Popularity: ): Developing products that: 1) Protect humans against the debilitating side effects of cancer chemotherapy and radiotherapy, and 2) Protect animals ...
Karo Bio AB (Popularity: ): A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.
|
 |
Related Press |
 |
Medical Identification Jewelry Recommended for Alzheimer's Patients Residing in Florida Assisted Living Facilities (Popularity: ): While it has always been a good idea for individuals with Alzheimer's disease to wear a medical ID clearly stating ...
ExonHit Builds A New Organisation (Popularity: ): ExonHit Therapeutics, a drug and diagnostic discovery company, today announced that it has created two commercial business units: the Molecular ...
DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease (Popularity: ): Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety ...
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases (Popularity: ): Bayer HealthCare (NYSE: BAY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that the companies have entered into a collaboration ...
Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis (Popularity: ): Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment has been completed in the REFLEX ...
|
 |
Related Articles |
 |
|
|
 |
|
 |
| |
| | |
|
|
|
© 2003-2008, ABC-Directory.Com. All Rights Reserved
|
|
|
 |
|
 |
|